ALLMedicine™ Aortic Regurgitation Center
Research & Reviews 1,717 results
https://doi.org/10.1111/echo.15531
Echocardiography (Mount Kisco, N.Y.); Kahraman N, Topal D et. al.
Feb 2nd, 2023 - Left ventricular outflow stenosis can develop at the supravalvular, valvular, and subvalvular levels. Resection of strictures at the diffuse subvalvular level is very difficult. In such pathologies, Konno-Rastan procedure provides very successful ...
https://doi.org/10.1097/HCO.0000000000001020
Current Opinion in Cardiology; Verma R, Cohen G et. al.
Feb 1st, 2023 - Bicuspid aortic valve (BAV) disease is observed in 1-2% of the general population. In addition to valve-related complications (such as aortic stenosis and aortic regurgitation), individuals with BAV often develop dilatation of the proximal aorta (...
https://clinicaltrials.gov/ct2/show/NCT05601453
Jan 27th, 2023 - Between 1.4 and 2.8% of all patients undergoing transcatheter heart valve (THV) implantation require a second THV implanted into the previously implanted THV because of clinically significant aortic regurgitation [1-3]. 90% of THV-in-THV implants ...
https://doi.org/10.1007/s00246-023-03100-5
Pediatric Cardiology; Alshahrani D, Linnane N et. al.
Jan 26th, 2023 - Transcatheter closure of Perimembranous VSDs (PMVSD) remains challenging particularly in infants. The aim of this study is to evaluate the efficacy and safety of transfemoral PMVSD device closure in infants weighing ≤ 10 kg in a single centre. Ret...
https://doi.org/10.1007/s10554-023-02800-6
The International Journal of Cardiovascular Imaging; Galdino BF, Amaral AM et. al.
Jan 22nd, 2023 - We aimed to evaluate the reasons for disagreement between screening echocardiography (echo), acquired by nonexperts, and standard echo in the Brazilian primary care (PC). Over 20 months, 22 PC workers were trained on simplified handheld (GE VSCAN)...
Clinicaltrials.gov 72 results
https://clinicaltrials.gov/ct2/show/NCT05601453
Jan 27th, 2023 - Between 1.4 and 2.8% of all patients undergoing transcatheter heart valve (THV) implantation require a second THV implanted into the previously implanted THV because of clinically significant aortic regurgitation [1-3]. 90% of THV-in-THV implants ...
https://clinicaltrials.gov/ct2/show/NCT05539573
Jan 12th, 2023 - There are four leading causes of valvular aortic valve stenosis, namely: calcific aortic stenosis, congenital aortic valve malformations, rheumatic aortic valve stenosis, and endocarditis. Calcific aortic valve stenosis is a chronic progressive di...
https://clinicaltrials.gov/ct2/show/NCT05536310
Jan 11th, 2023 - Aortic stenosis (AS) is a narrowing of the aortic valve opening causing restricted blood flow from the left ventricle to the aorta and may also affect the pressure in the left atrium. Aortic regurgitation (AR) is a condition where the aortic valve...
https://clinicaltrials.gov/ct2/show/NCT05680610
Jan 11th, 2023 - A considerable proportion of patients who require mitral valve replacement present with a coexisting pathology of the aortic valve (AV). Rheumatic fever remains the leading cause for combined disease (1) Early series found that one-third of rheuma...
https://clinicaltrials.gov/ct2/show/NCT02732704
Nov 18th, 2022 - This study will examine the use of TAVR (Transcatheter Aortic Valve Replacement), which is a minimally invasive procedure designed to replace the aortic valve inside the heart. In this study, TAVR will be performed using the JenaValve Pericardial ...
News 173 results
https://www.medscape.com/viewarticle/974304
May 19th, 2022 - Transcatheter aortic valve implantation (TAVI) using the JenaValve Trilogy system met its primary safety and efficacy endpoints in the first real-world test of the novel valve in high-risk patients with severe aortic regurgitation (AR). Technical ...
https://www.medscape.com/viewarticle/962484
Nov 8th, 2021 - The SURTAVI trial has become the second major face-off between transcatheter and surgical aortic valve replacement (TAVR and SAVR, respectively), after PARTNER 2A, to show parity in 5-year clinical outcomes in patients with severe, symptomatic aor...
https://www.medscape.com/viewarticle/950702
May 6th, 2021 - Patients who suffer a stroke during hospitalization for infective endocarditis (IE) after transcatheter aortic valve replacement (TAVR) have a dismal prognosis, with more than half dying during the index hospitalization and two thirds within the f...
https://www.medscape.com/viewarticle/943287
Dec 29th, 2020 - The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a drug safety update highlighting a small risk of heart valve regurgitation with the use of systemic and inhaled fluoroquinolones. The update follows a European review of ep...
https://www.medpagetoday.com/cardiology/pci/90291
Dec 17th, 2020 - Transcatheter interventions get more love in updated valvular heart disease guidelines from the American College of Cardiology (ACC) and American Heart Association (AHA). Patients with severe aortic stenosis who have choices for intervention shoul...